Effectiveness and Safety of Dabigatran and Warfarin in Real-World US Patients With Non-Valvular Atrial Fibrillation: A Retrospective Cohort Study [Health Services and Outcomes Research]
Conclusions
Dabigatran could be a safe and potentially more effective alternative to warfarin in patients with atrial fibrillation managed in routine practice settings.
Source: JAHA:Journal of the American Heart Association - Category: Cardiology Authors: Lauffenburger, J. C., Farley, J. F., Gehi, A. K., Rhoney, D. H., Brookhart, M. A., Fang, G. Tags: Health Services and Outcomes Research Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Coumadin | Databases & Libraries | Gastroenterology | Health | Heart | Heart Attack | Hemorrhagic Stroke | Ischemic Stroke | Medicare | Pradaxa | Stroke | Study | Warfarin